tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market

KalVista Pharmaceuticals (KALV) Income Statement

Compare
573 Followers

KalVista Pharmaceuticals Income Statement

Last quarter (Q2 2026), KalVista Pharmaceuticals's total revenue was $13.69M, an increase of Infinity% from the same quarter last year. In Q2, KalVista Pharmaceuticals's net income was $-49.48M. See KalVista Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -86.17M$ 0.00$ 0.00$ -41.29M
Operating Expenses
$ 188.00M$ 54.28M$ 110.87M$ 96.61M$ 16.64M
Depreciation and Amortization
$ 941.00K$ 816.00K$ 718.00K$ 564.00K$ 537.00K
EBITDA
$ -173.33M$ -134.28M$ -94.37M$ -80.75M$ -57.39M
Operating Income
$ -188.00M$ -140.44M$ -110.87M$ -96.61M$ -57.92M
Other Income/Expenses
$ 7.94M$ 5.35M$ 17.96M$ 14.27M$ 11.68M
Pretax Income
$ -180.05M$ -135.10M$ -92.91M$ -82.34M$ -46.24M
Net Income
$ -183.44M$ -126.64M$ -92.91M$ -82.34M$ -46.24M
Per Share Metrics
Basic EPS
$ -3.69$ -3.44$ -3.33$ -3.36$ -2.33
Diluted EPS
$ -3.69$ -3.44$ -3.33$ -3.36$ -2.33
Weighted Average Shares Outstanding
49.65M 36.79M 27.89M 24.47M 19.09M
Weighted Average Shares Outstanding (Diluted)
49.65M 36.79M 27.89M 24.47M 19.09M
Currency in USD

KalVista Pharmaceuticals Earnings and Revenue History